Darcie Sandschafer Selected Research

Stomach Neoplasms (Stomach Cancer)

2/2024

Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Darcie Sandschafer Research Topics

Disease

3	Neoplasms (Cancer) 01/2023 - 01/2021
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2021
1	Stomach Neoplasms (Stomach Cancer) 02/2024
1	Chemotherapy-Induced Febrile Neutropenia 01/2023
1	Neutropenia 01/2023
1	Disease Progression 12/2021

Drug/Important Bio-Agent (IBA)

4	Biosimilar PharmaceuticalsIBA 02/2024 - 01/2021
3	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2021
2	Trastuzumab (Herceptin)FDA Link 02/2024 - 01/2021
1	Filgrastim (Neupogen)FDA Link 01/2023
1	pegfilgrastim (Neulasta)FDA Link 01/2023

Therapy/Procedure

1	Drug Tapering 01/2023
1	Treatment Delay 01/2023
1	Drug Therapy (Chemotherapy) 01/2023